Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
Latest Information Update: 16 Feb 2023
At a glance
- Drugs Vadadustat (Primary)
- Indications SARS-CoV-2 acute respiratory disease
- Focus Therapeutic Use
- Acronyms VSTAT
- 09 Feb 2023 Status changed from active, no longer recruiting to completed.
- 04 Aug 2022 Results presented in an Akebia Therapeutics media release.
- 04 Aug 2022 According to an Akebia Therapeutics media release, the study was partially funded by Akebia.